Alzheimer's disease-specific transcriptomic and epigenomic changes in the tryptophan catabolic pathway.

MLA

Choe, Kyonghwan, et al. “Alzheimer’s Disease-Specific Transcriptomic and Epigenomic Changes in the Tryptophan Catabolic Pathway.” Alzheimer’s Research & Therapy, vol. 16, no. 1, Nov. 2024, pp. 1–16. EBSCOhost, https://doi.org/10.1186/s13195-024-01623-4.

APA

Choe, K., Ali, M., Lardenoije, R., Riemens, R. J. M., Pishva, E., Bickel, H., Weyerer, S., Hoffmann, P., Pentzek, M., Riedel-Heller, S., Wiese, B., Scherer, M., Wagner, M., Mastroeni, D., Coleman, P. D., Ramirez, A., Ramakers, I. H. G. B., Verhey, F. R. J., Rutten, B. P. F., & Kenis, G. (2024). Alzheimer’s disease-specific transcriptomic and epigenomic changes in the tryptophan catabolic pathway. Alzheimer’s Research & Therapy, 16(1), 1–16. https://doi.org/10.1186/s13195-024-01623-4

Chicago

Choe, Kyonghwan, Muhammad Ali, Roy Lardenoije, Renzo J.M. Riemens, Ehsan Pishva, Horst Bickel, Siegfried Weyerer, et al. 2024. “Alzheimer’s Disease-Specific Transcriptomic and Epigenomic Changes in the Tryptophan Catabolic Pathway.” Alzheimer’s Research & Therapy 16 (1): 1–16. doi:10.1186/s13195-024-01623-4.